Profund Advisors’s Integra LifeSciences IART Stock Holding History

Profund Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,365	Closed	-$280K	–	1160
2022 Q1	$280K	Buy	4,365 +163	+4%	+$10.7K	0.01%	995
2021 Q4	$281K	Sell	4,202 -113	-3%	-$7.64K	0.01%	1031
2021 Q3	$295K	Sell	4,315 -453	-10%	-$32K	0.01%	969
2021 Q2	$325K	Buy	4,768 +34	+0.7%	+$2.4K	0.01%	991
2021 Q1	$327K	Sell	4,734 -187	-4%	-$12.7K	0.01%	904
2020 Q4	$319K	Sell	4,921 -1,213	-20%	-$65.3K	0.01%	787
2020 Q3	$290K	Buy	+6,134	New	+$292K	0.01%	682
2020 Q1	–	Sell	-5,817	Closed	-$339K	–	956
2019 Q4	$339K	Sell	5,817 -49	-0.8%	-$2.92K	0.01%	838
2019 Q3	$352K	Sell	5,866 -1,805	-24%	-$108K	0.02%	822
2019 Q2	$428K	Sell	7,671 -756	-9%	-$38.9K	0.02%	718
2019 Q1	$470K	Buy	8,427 +2,508	+42%	+$128K	0.02%	656
2018 Q4	$267K	Sell	5,919 -2,902	-33%	-$159K	0.02%	839
2018 Q3	$581K	Sell	8,821 -212	-2%	-$13.2K	0.02%	685
2018 Q2	$582K	Sell	9,033 -4,242	-32%	-$263K	0.02%	682
2018 Q1	$735K	Buy	13,275 +2,682	+25%	+$141K	0.03%	570
2017 Q4	$507K	Sell	10,593 -675	-6%	-$33K	0.02%	810
2017 Q3	$569K	Buy	11,268 +979	+10%	+$50.3K	0.02%	690
2017 Q2	$561K	Sell	10,289 -1,060	-9%	-$50.6K	0.03%	665
2017 Q1	$478K	Sell	11,349 -2,365	-17%	-$101K	0.02%	878
2016 Q4	$588K	Buy	13,714 +4,354	+47%	+$177K	0.03%	784
2016 Q3	$386K	Buy	9,360 +1,520	+19%	+$63.7K	0.02%	936
2016 Q2	$313K	Sell	7,840 -4	-0.1%	-$144	0.02%	1100
2016 Q1	$264K	Sell	7,844 -2,806	-26%	-$87.4K	0.01%	1170
2015 Q4	$361K	Buy	10,650 +3,592	+51%	+$112K	0.02%	830
2015 Q3	$210K	Sell	7,058 -5,461	-44%	-$171K	0.01%	1078
2015 Q2	$345K	Sell	12,519 -3,041	-20%	-$81K	0.01%	1027
2015 Q1	$392K	Buy	15,560 +4,903	+46%	+$116K	0.02%	1066
2014 Q4	$236K	Buy	+10,657	New	+$216K	0.01%	1265
2014 Q3	–	Sell	-13,013	Closed	-$250K	–	1378
2014 Q2	$250K	Buy	13,013 +257	+2%	+$4.79K	0.01%	1315
2014 Q1	$240K	Sell	12,756 -13,974	-52%	-$270K	0.01%	1346
2013 Q4	$521K	Buy	26,730 +4,377	+20%	+$80.3K	0.02%	999
2013 Q3	$368K	Buy	+22,353	New	+$359K	0.02%	1159

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Profund Advisors's IART Position: Q2 2022 in Review

Profund Advisors sold out of Integra LifeSciences (IART) in Q2 2022, closing a stake of 4,365 shares — an estimated $280K sold.

Profund Advisors first reported a position in IART in Q3 2013 and held it in 32 quarters. The position peaked at $735K in Q1 2018. 284 funds tracked by Wall St. Rank hold IART as of Q2 2022.

Profund Advisors reported no remaining Integra LifeSciences position as of Q2 2022 after selling out during the quarter.
Profund Advisors sold 4,365 Integra LifeSciences shares in Q2 2022, an estimated $280K.
Profund Advisors first reported a position in Integra LifeSciences in Q3 2013 and held it in 32 quarters.
Profund Advisors's Integra LifeSciences position peaked at $735K in Q1 2018.
284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2022.

Based on Profund Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.